Prognostic value of the platelet-neutrophil-monocyte-lymphocyte ratio in patients with non-metastatic renal cell carcinoma who underwent nephrectomy
PNMLR is a promising prognostic marker for non-metastatic RCC. However, its moderate discriminative ability suggests that PNMLR should be used in conjunction with other established clinical parameters. Further validation, particularly in independent, contemporary external cohorts, is essential to fully harness its clinical utility.
Authors
- Bin Zhang (ORCID: https://orcid.org/0000-0002-6631-7647)
- Dan Chen (ORCID: https://orcid.org/0000-0001-7665-7787)
- Yaxiong Tang (ORCID: https://orcid.org/0000-0003-1103-7872)
Institutions
- Sichuan University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1186/s12885-025-14418-z
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00